Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.51 |
| ▸ | MAOB | P27338 | 5/20 | 0.51 |
| ▸ | GRM5 | P41594 | 5/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15327084 | 0.95 | MAOA (0.47) | MAOAMAOBGRM5L3MBTL1TDP1 | |
| SCHEMBL3447013 | 0.91 | MAOA (0.49) | MAOAMAOBGRM5L3MBTL1TDP1 | |
| SCHEMBL31634592 | 0.87 | MAOA (0.66) | MAOAMAOBL3MBTL1TDP1MAPT | |
| SCHEMBL2828515 | 0.87 | MAOA (0.66) | MAOAMAOBL3MBTL1TDP1MAPT | |
| SCHEMBL10414698 | 0.87 | MAOA (0.66) | MAOAMAOBL3MBTL1TDP1MAPT | |
| SCHEMBL30970619 | 0.85 | MAOA (0.56) | MAOAMAOBL3MBTL1TDP1MAPT | |
| SCHEMBL1501398 | 0.85 | MAOA (0.56) | MAOAMAOBL3MBTL1TDP1MAPT | |
| SCHEMBL84254 | 0.85 | MAOA (0.56) | MAOAMAOBL3MBTL1TDP1MAPT | |
| SCHEMBL72823 | 0.83 | GRM5 (0.66) | GRM5TDP1MAPTALOX15 | |
| SCHEMBL42261 | 0.83 | MAOA (0.53) | MAOAMAOBL3MBTL1TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100059261-A1 | REACTIVE MONOMER AND RESIN COMPOSITION CONTAINING SAME | AMT LABORATORY CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| US-5760168-A | CONTROLLED MOLECULAR WEIGHT; FILMS, MOLDINGS, ADHESIVES, COMPOSITES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AEUONAUTICS AND SPACE ADMINISTRATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5681967-A | ENDCAPPING POLYAMIC ACIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1997-10-28 | — | — | US | disclosed |
| US-5567800-A | MOLECULAR WEIGHT CONTROLLED AROMATIC POLYIMIDES; ELONGATION, HIGH GLASS TRANSITION TEMPERATURE, TOUGHNESS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1996-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100059261-A1 | REACTIVE MONOMER AND RESIN COMPOSITION CONTAINING SAME | RAD51, ACTR2, ARID2 | MAOA 2552/4885MAOB 1863/4885GRM5 893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.